SOCS3 and atherosclerosis: Thus, EPAC1 is involved in multiple anti-inflammatory processes in VECs and the links between EPAC1 and SOCS3 and the development of atherosclerosis/NIH indicate that EPAC1 regulation should be considered as a potential therapeutic avenue for the future treatment of cardiovascular disease.